ProfileOfResearchers

Identified 4

1

TITLE: Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial Full Text
AUTHORS: Knop, S; Mateos, MV; Dimopoulos, MA; Suzuki, K; Jakubowiak, A; Doyen, C; Lucio, P; Nagy, Z; Usenko, G; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Losava, G; Fujisaki, T; Garg, M; Wang, JP; Wroblewski, S; Kudva, A; Gries, KS; Fastenau, J; San Miguel, J; Cavo, M; ...More
PUBLISHED: 2021, SOURCE: BMC CANCER, VOLUME: 21, ISSUE: 1

INDEXED IN:

Scopus

WOS

2

TITLE: Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
AUTHORS: Michele Cavo; Francesca Gay; Meral Beksac; Lucia Pantani; Maria Teresa Petrucci; Meletios A Dimopoulos; Luca Dozza; Bronno van der Holt; Sonja Zweegman; Stefania Oliva; Vincent H J van der Velden; Elena Zamagni; Giuseppe A Palumbo; Francesca Patriarca; Vittorio Montefusco; Monica Galli; Vladimir Maisnar; Barbara Gamberi; Markus Hansson; Angelo Belotti; Ludek Pour; Paula Ypma; Mariella Grasso; Alexsandra Croockewit; Stelvio Ballanti; Massimo Offidani; Iolanda D Vincelli; Renato Zambello; Anna Marina Liberati; Niels Frost Andersen; Annemiek Broijl; Rossella Troia; Anna Pascarella; Giulia Benevolo; Mark David Levin; Gerard Bos; Heinz Ludwig; Sara Aquino; Anna Maria Morelli; Ka Lung Wu; Rinske Boersma; Roman Hajek; Marc Durian; Peter von dem Borne; Tommaso Caravita di Toritto; Thilo Zander; Giorgina Specchia; Anders Waage; Peter Gimsing; Ulf Henrik Mellqvist; Marinus van Marwijk Kooy; Monique Minnema; Caroline Mandigers; Anna Maria Cafro; Angelo Palmas; Susanna Carvalho; Andrew Spencer; Mario Boccadoro; Pieter Sonneveld; ...More
PUBLISHED: 2020, SOURCE: LANCET HAEMATOLOGY, VOLUME: 7, ISSUE: 6

INDEXED IN:

Scopus

WOS

3

TITLE: Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1 Full Text
AUTHORS: Maria Victoria Mateos; Tamas Masszi; Norbert Grzasko; Markus Hansson; Irwindeep Sandhu; Ludek Pour; Luisa Viterbo; Sharon R Jackson; Anne Marie Stoppa; Peter Gimsing; Mehdi Hamadani; Gabriela Borsaru; Deborah Berg; Jianchang C Lin; Alessandra Di Bacco; Helgi van de Velde; Paul G Richardson; Philippe Moreau;
PUBLISHED: 2017, SOURCE: HAEMATOLOGICA, VOLUME: 102, ISSUE: 10

INDEXED IN:

Scopus

WOS

4

TITLE: Efficacy and safety of ixazomib plus lenalidomidedexamethasone (IRd) vs placebo-rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM) by cytogenetic risk status in the global phase III Tourmaline-MM1 study.
AUTHORS: Paul G Richardson; Herve Avet Loiseau; Antonio Palumbo; Luisa Viterbo; Arnon Nagler; Peter Ganly; Dina Ben Yehuda; Jesus San Miguel; Vincent V Rajkumar; Ludek Pour; Christian Langer; Nizar J Bahlis; Andrzej Pluta; Tamas Masszi; Deborah Berg; Jianchang C Lin; Helgi Van De Velde; Dixie Lee Esseltine; Alessandra di Baccot; Philippe Moreau;
PUBLISHED: 2016, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 15

INDEXED IN:

WOS

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service